Is there a role for the use of radical lymph node dissection in the surgical management of resectable non-small cell lung cancer?

Interactive Cardiovascular and Thoracic Surgery

Volumn 3, Issue 2, 2004, Pages 294-299

  Barnard, James ^a   Dunning, Joel ^a   Musleh, Ghassan ^a   Odom, Nick ^a  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Evidence based medicine; Lung neoplasms; Lymph node excision; Thoracic surgery

Indexed keywords

ARTICLE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; HUMAN; LUNG NON SMALL CELL CANCER; LYMPH NODE DISSECTION; PRIORITY JOURNAL; SAMPLING; SURGICAL TECHNIQUE; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 2442486540     PISSN: 15699293     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.icvts.2003.12.004     Document Type: Article

References (12)

1. Dunning J., Prendergast B., Kevin Mackway-Jones K. Towards evidence based medicine in cardiothoracic surgery: best BETS. Interact Cardiovasc Thorac Surg. 2:2003;416-419
2. Izbicki J., Passlick B., Pantel K., Pichlmeier U., Hosch B., Karg O., Thetter O. Effectiveness of radical systematic mediastinal lymphadenectomy in patients with resectable non-small cell lung cancer. Ann Surg. 277:(1):1998;138-144
3. Izbicki J.R., Passlick B., Karg O., Bloechle C., Pantel K., Knoefel W.T., Thetter O. Impact of radical systematic mediastinal lymphadenectomy on tumor staging in lung cancer. Ann Thorac Surg. 59:(1):1995;209-214
4. Passlick B., Kubuschock B., Sienel W., Thetter O., Pantel K., Izbicki J.R. Mediastinal lymphadenectomy in non-small cell lung cancer: effectiveness in patients with or without nodal micrometastases - results of a preliminary study. Eur J Cardiothorac Surg. 21:2002;520-526
5. Wu Y., Huang Z., Wang S., Yang X., Ou W. A randomized trial of systematic nodal dissection in resectable non-small cell lung cancer. Lung Cancer. 36:2002;1-6
6. Keller S., Adak S., Wagner H., Johnson D. Mediastinal lymph node dissection improves survival in patients with stages II and IIIa non small cell lung cancer. Ann Thorac Surg. 70:2000;358-366
7. Gajra A., Newman N., Gamble G., Kohman L., Graziano S. Effect of number of lymph nodes sampled on outcome in patients with stage I non-small-cell lung cancer. J Clin Oncol. 21:2003;1029-1034
8. Sugi K., Nawata K., Fujita N., Ueda K., Tanaka T., Matsuoka T., Kaneda Y., Esato K. Systematic lymph node dissection for clinically diagnosed peripheral non-small-cell lung cancer less than 2 cm in diameter. World J Surg. 22:1998;290-295
9. Wu Y., Lin C., Hsu W., Huang B., Huang M., Wang L. Long-term results of pathological stage I non-small cell lung cancer: validation of using the number of totally removed lymph nodes as a staging control. Eur J Cardiothorac Surg. 24:2003;994-1001
10. Feinstein A.R., Sosin D.M., Wells C.K. The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med. 312:(25):1985;1604-1608
11. British Thoracic Society. Guidelines on the selection of patients with lung cancer for surgery. Thorax. 56:2001;89-108
12. Vansteenkiste J.F., De Leyn P.R., Deneffe G.J., Lerut T.E., Demedts M.G. Clinical prognostic factors in surgically treated stage IIIA-N2 non-small cell lung cancer: analysis of the literature. Lung Cancer. 19:(3):1998;219